Getein Biotech Inc (603387) - Total Liabilities

Latest as of September 2025: CN¥1.04 Billion CNY ≈ $151.48 Million USD

Based on the latest financial reports, Getein Biotech Inc (603387) has total liabilities worth CN¥1.04 Billion CNY (≈ $151.48 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 603387 cash flow conversion to assess how effectively this company generates cash.

Getein Biotech Inc - Total Liabilities Trend (2012–2024)

This chart illustrates how Getein Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. Check Getein Biotech Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Getein Biotech Inc Competitors by Total Liabilities

The table below lists competitors of Getein Biotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Kerjaya Prospek Group Bhd KLSE:7161	Malaysia	RM944.13 Million
Media and Games Invest PLC XETRA:M8G	Germany	€746.49 Million
Shenzhen Refond Optoelectronics Co Ltd SHE:300241	China	CN¥1.39 Billion
Banco do Estado do Rio Grande do Sul S.A SA:BRSR3	Brazil	R$152.39 Billion
Yabao Pharmaceutical Group Co Ltd SHG:600351	China	CN¥585.77 Million
SmartFinancial, Inc. NYSE:SMBK	USA	$5.19 Billion
Ocean’s King Lighting Science & Technology Co Ltd SHE:002724	China	CN¥581.18 Million
Garware Technical Fibres Limited NSE:GARFIBRES	India	Rs5.79 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Getein Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Getein Biotech Inc.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.32	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.38	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.27	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Getein Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Getein Biotech Inc (2012–2024)

The table below shows the annual total liabilities of Getein Biotech Inc from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥986.42 Million ≈ $144.34 Million	-4.27%
2023-12-31	CN¥1.03 Billion ≈ $150.78 Million	+1.73%
2022-12-31	CN¥1.01 Billion ≈ $148.21 Million	+17.24%
2021-12-31	CN¥863.90 Million ≈ $126.42 Million	+24.13%
2020-12-31	CN¥695.95 Million ≈ $101.84 Million	+113.49%
2019-12-31	CN¥325.98 Million ≈ $47.70 Million	+74.11%
2018-12-31	CN¥187.23 Million ≈ $27.40 Million	+57.50%
2017-12-31	CN¥118.87 Million ≈ $17.39 Million	+30.45%
2016-12-31	CN¥91.13 Million ≈ $13.33 Million	+53.21%
2015-12-31	CN¥59.48 Million ≈ $8.70 Million	+44.16%
2014-12-31	CN¥41.26 Million ≈ $6.04 Million	-41.41%
2013-12-31	CN¥70.42 Million ≈ $10.31 Million	+43.27%
2012-12-31	CN¥49.15 Million ≈ $7.19 Million	--

About Getein Biotech Inc

SHG:603387 China Medical Devices

Market Cap

$716.15 Million

CN¥4.89 Billion CNY

Market Cap Rank

#10800 Global

#3183 in China

Share Price

CN¥9.65

Change (1 day)

+0.00%

52-Week Range

CN¥7.65 - CN¥10.65

All Time High

CN¥21.49